# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015433
Filing Date
2024-11-13
Accepted
2024-11-13 07:30:34
Documents
83
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lqda-20240930x10q.htm iXBRL | 10-Q | 1955259
2 | EX-10.4 | lqda-20240930xex10d4.htm | EX-10.4 | 584091
3 | EX-10.5 | lqda-20240930xex10d5.htm | EX-10.5 | 72534
4 | EX-31.1 | lqda-20240930xex31d1.htm | EX-31.1 | 15304
5 | EX-31.2 | lqda-20240930xex31d2.htm | EX-31.2 | 15333
6 | EX-32.1 | lqda-20240930xex32d1.htm | EX-32.1 | 7569
7 | EX-32.2 | lqda-20240930xex32d2.htm | EX-32.2 | 7576
8 | GRAPHIC | lqda-20240930x10q002.jpg | GRAPHIC | 631
9 | GRAPHIC | lqda-20240930xex10d5001.jpg | GRAPHIC | 939
| Complete submission text file | 0001558370-24-015433.txt |  | 8943662

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | EX-101.SCH | lqda-20240930.xsd | EX-101.SCH | 69863
11 | EX-101.CAL | lqda-20240930_cal.xml | EX-101.CAL | 49206
12 | EX-101.DEF | lqda-20240930_def.xml | EX-101.DEF | 194269
13 | EX-101.LAB | lqda-20240930_lab.xml | EX-101.LAB | 546879
14 | EX-101.PRE | lqda-20240930_pre.xml | EX-101.PRE | 369395
86 | EXTRACTED XBRL INSTANCE DOCUMENT | lqda-20240930x10q_htm.xml | XML | 1377391

Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 241451183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)